NCT01860040 Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01859728 GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer Status UNKNOWN Phase PHASE2
NCT01858883 Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01852890 Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I Status COMPLETED Phase PHASE1
NCT01851174 Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT01850303 Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01846390 Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01844791 An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients Status COMPLETED Phase PHASE2
NCT01839799 A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01839487 PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01836432 Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT01834235 QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01834170 EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01833546 A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01830322 Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE2
NCT01828736 Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01828034 First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01822756 An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01821612 Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer Status COMPLETED Phase EARLY_PHASE1